These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20659122)

  • 41. Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial.
    Fallah Arani S; Neumann H; Hop WC; Thio HB
    Br J Dermatol; 2011 Apr; 164(4):855-61. PubMed ID: 21175564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia.
    Fozza C; Dore F; Bonfigli S; Podda L; Longinotti M
    Eur J Dermatol; 2005; 15(4):271-3. PubMed ID: 16048757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
    Feldman SR; Nijsten T; Margolis DJ; Rolstad T
    J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ciclosporin in psoriasis consensus statement.
    Menter A
    Br J Dermatol; 2005 Apr; 152(4):811; author reply 811. PubMed ID: 15840127
    [No Abstract]   [Full Text] [Related]  

  • 46. Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
    Yamauchi PS; Lowe NJ
    Int J Dermatol; 2008 Feb; 47(2):202-4. PubMed ID: 18211500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood psoriasis.
    Benoit S; Hamm H
    Clin Dermatol; 2007; 25(6):555-62. PubMed ID: 18021892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of cyclosporin A on psoriasis].
    Müller W; Herrmann B
    Dtsch Med Wochenschr; 1979 Jul; 104(29):1047. PubMed ID: 467247
    [No Abstract]   [Full Text] [Related]  

  • 49. Psoriasis treatment: traditional therapy.
    Lebwohl M; Ting PT; Koo JY
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. microRNAs involved in psoriasis and cardiovascular diseases.
    Sileno S; Beji S; D'Agostino M; Carassiti A; Melillo G; Magenta A
    Vasc Biol; 2021; 3(1):R49-R68. PubMed ID: 34291190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study.
    Singh S; Dogra S; Shafiq N; Bhansali A; Malhotra S
    Int J Appl Basic Med Res; 2017; 7(3):169-175. PubMed ID: 28904916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atherosclerosis as a systemic feature of psoriasis.
    Alexandroff AB; Pauriah M; Lang CC; Struthers AD; Armstrong DJ
    Clin Exp Dermatol; 2011 Jul; 36(5):451-2. PubMed ID: 20659122
    [No Abstract]   [Full Text] [Related]  

  • 56. Psoriasis. Inflammatory disorder may be more than skin deep.
    Mayo Clin Womens Healthsource; 2009 Dec; 13(12):4-5. PubMed ID: 19881449
    [No Abstract]   [Full Text] [Related]  

  • 57. [Psoriasis and atherothrombotic disease].
    Ahlehoff O; Gislason GH; Skov L; Hansen PR
    Ugeskr Laeger; 2010 Jun; 172(26):1983-6. PubMed ID: 20654288
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.